Clinical Report: Utilizing VV-ECMO without Anticoagulation in Trauma Cases
Overview
This report discusses the use of veno-venous extracorporeal membrane oxygenation (VV-ECMO) without systemic anticoagulation in 14 trauma patients with severe hypoxemic respiratory failure. The findings indicate that while thrombotic complications occurred, they were manageable, and major bleeding events were consistent with the high-risk nature of the patient population.
Background
Severe hypoxemic respiratory failure is a significant cause of mortality in trauma patients, and VV-ECMO has emerged as a critical intervention when conventional mechanical ventilation fails. The traditional requirement for systemic anticoagulation during ECMO poses a heightened risk of bleeding, particularly in trauma patients who may already have coagulopathy. Understanding the balance between managing thrombotic and bleeding risks is essential for optimizing outcomes in this vulnerable population.
Data Highlights
Parameter
Value
Median Age
47 years
Median Duration of VV-ECMO
227.3 hours
ICU Mortality
21.4%
28-Day Survival
78.6%
Major Bleeding Events
28.6%
Thrombotic Complications
35.7% (DVT)
Key Findings
14 trauma patients with severe hypoxemic respiratory failure were treated with VV-ECMO without anticoagulation.
Median PaO₂/FiO₂ ratio before ECMO initiation was 58.0, indicating profound hypoxemia.
Thrombotic complications included oxygenator thrombosis in 14.3% of patients and deep vein thrombosis in 35.7%.
Major bleeding occurred in 28.6% of patients, but no catastrophic bleeding was directly linked to the absence of anticoagulation.
ICU mortality was 21.4%, with no deaths attributed to ECMO-related complications.
Clinical Implications
The findings suggest that VV-ECMO without systemic anticoagulation may be a viable option for selected trauma patients, provided there is careful monitoring of thrombotic and bleeding risks. Clinicians should weigh the benefits of avoiding anticoagulation against the potential for thrombotic events, particularly in high-risk trauma settings.
Conclusion
This experience underscores the feasibility of an anticoagulation-free VV-ECMO approach in trauma patients, highlighting the need for individualized management strategies in this complex clinical scenario.
A large English cohort study found influenza hospitalization more than doubled the short-term risk of new-onset diabetes, with prediabetes and critical care admission among the strongest predictors.
In a cohort study reported in JAMA Oncology, Fox et al found that approximately half of older patients with metastatic non–small cell lung cancer (NSCLC) have received systemic therapy in the United S...
